WordNet

a special situation; "this thing has got to end"; "it is a remarkable thing"
a separate and self-contained entity
an action; "how could you do such a thing?"
an artifact; "how does this thing work?"
an entity that is not named specifically; "I couldnt tell what the thing was"
any attribute or quality considered as having its own existence; "the thing I like about her is ..."
a persistent illogical feeling of desire or aversion; "he has a thing about seafood"; "she has a thing about him"
a special abstraction; "a thing of the spirit"; "things of the heart"
a special objective; "the thing is to stay in bounds"
a statement regarded as an object; "to say the same thing in other terms"; "how can you say such a thing?"
an event; "a funny thing happened on the way to the..."
relating to or located near the organ that produces tears (同)lachrymal
of or relating to tears (同)lachrymal
any of various organs that synthesize substances needed by the body and release it through ducts or directly into the bloodstream (同)secretory organ, secretor, secreter

PrepTutorEJDIC

〈C〉(形のある)『物』,物体;(生物に対しての)『無生物』 / 〈C〉(形のない)『もの』,事,事柄,でき事 / 《複数形で》事情,事態,状勢,状況 / 《複数形で》(すべての)事物,事柄 / 《通例 the~》(努力・活動などの)目的,目標 / 〈C〉衣服,衣類・《one's things》持ち物,所持品,身の回り品 / 《複数形で》道具,用具・〈C〉《親愛・哀れみ・軽べつなどの感情をこめて》人,者,やつ / 《the~》《話》(…の)流行《+in+名》
《所有・所属》…『の』,…のものである,…に属する・《材料・要素》…『でできた』,から成る・《部分》…『の』[『中の』] ・《数量・単位・種類を表す名詞に付いて》…の・《原因・動機》…『で』,のために(because of) ・《主格関係》…『の』,による,によって・《目的格関係》…『を』,の・《同格関係》…『という』・《関係・関連》…『についての』[『の』],の点で・《抽象名詞などと共に》…の[性質をもつ] ・《『It is』+『形』+『of』+『名』+『to』 doの形で,ofの後の名詞を意味上の主語として》・《分離》…『から』・《起原・出所》…『から』[『の』](out of) ・《『名』+『of』+『a』(『an』)+『名』の形で》…のような・《『名』+『of』+『mine』(『yours, his』など独立所有格)の形で》…の…・《時》(1)《副詞句を作って》…に《形容詞句を作って》…の・《時刻》《米》…前(to,《米》before)
《前述の名詞または文脈でそれと分かる名詞に付けて》『その』,あの,名の / 《唯一の事物に付けて》 / 《方角・自然現象に付けて》 / 《用具・楽器・特定の病気などに付けて》 / 《修飾吾[句]を伴う名詞に付けて》 / 《単数普通名詞に付けて》(1)《種族全体》…『というもの』 / 《複数名詞または集合名詞に付けて》 / 《単位》『…につき;…単位[で]』 / 《身体の一部に付けて,所有格に代わる》 / 《形容詞に付けて》 / 《固有名詞に付けて》 / 《強意用法に》『随一の』,典型的な / 《「the+比較級,the+比較級」の形で》『…すればするほどそれだけ』 / 《比較級の前に》(…につれて,のために)『それだけ』,ますます
=lachrymal / 涙腺(るいせん)の近くにある
(生物体内の)腺(せん)

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. シェーグレン症候群の臨床症状：外分泌腺障害 clinical manifestations of sjogrens syndrome exocrine gland disease
2. 唾石症 salivary gland stones
3. 唾液腺腫瘍：疫学、診断、評価、および病期分類 salivary gland tumors epidemiology diagnosis evaluation and staging
4. シェーグレン症候群の診断および分類 diagnosis and classification of sjogrens syndrome
5. 唾液腺腫瘍：限局性疾患の治療 salivary gland tumors treatment of locoregional disease

English Journal

Unusual Pleomorphic Adenoma of the Lacrimal Gland: Immunohistochemical Demonstration of PLAG1 and HMGA2 Oncoproteins.

Jakobiec FA1, Stagner AM2, Eagle RC Jr3, Lally SE4, Krane JF5.
Survey of ophthalmology.Surv Ophthalmol.2016 Aug 24. pii: S0039-6257(16)30065-0. doi: 10.1016/j.survophthal.2016.08.001. [Epub ahead of print]
A 49-year-old woman with a past history of breast cancer slowly developed painless, lowgrade right proptosis with 20/25 visual acuity and 20/20 in the uninvolved left eye. Imaging studies disclosed an oval to round superotemporal mass in the right lacrimal fossa without bone erosion. Excisional biop
PMID 27567603

Leiomyoma of the third eyelid in a dog.

Mathes RL1, Noble SJ2, Ellis AE3.
Veterinary ophthalmology.Vet Ophthalmol.2016 Jul;19(4):347-354. doi: 10.1111/vop.12305. Epub 2015 Aug 24.
A 14-year-old neutered male Dachshund presented for the evaluation of oculus dexter (OD) third eyelid elevation ongoing for approximately 2 months. Complete ophthalmic examination revealed a large, nonpainful, well-demarcated, soft mass at the base of the right third eyelid causing elevation and mi
PMID 26301321

Mutational landscape of lacrimal gland carcinomas and implications for treatment.

Bell D1, Sniegowski MC2, Wani K1, Prieto V1, Esmaeli B2.
Head & neck.Head Neck.2016 Apr;38 Suppl 1:E724-9. doi: 10.1002/hed.24078. Epub 2015 Jun 15.
BACKGROUND: Lacrimal gland carcinomas are rare. Identification of molecular abnormalities underlying lacrimal gland carcinogenesis is critical to the development of new targeted therapies for lacrimal gland carcinomas. The purpose of our study was to look for mutations that can be targeted as new tr
PMID 25899808